TMCITreace Medical Concepts, Inc.

$104M

Q3 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$33M+52.9% YoY

Gross Profit

$27M81.6% margin

Operating Income

-$11M-34.2% margin

Net Income

-$12M-36.7% margin

EPS (Diluted)

$-0.23

QoQ Revenue Growth

+10.3%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$13M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$156M

Total Liabilities

$94M

Stockholders' Equity

$62M

Cash & Equivalents

$89M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$33M	$22M	+52.9%
Gross Profit	$27M	$17M	+55.2%
Operating Income	-$11M	-$5M	-107.3%
Net Income	-$12M	-$6M	-89.0%

TMCI Q3 2022 Earnings — Treace Medical Concepts, Inc. Revenue & Financial Results | Market Cap Arena